SOADOR
AVNS

State of Alaska Department of Revenue’s Avanos Medical AVNS Stock Holding History

State of Alaska Department of Revenue’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Sell
17,879
-7,825
-30% -$183K ﹤0.01% 1447
2026
Q1 		$359K Hold
25,704
– – ﹤0.01% 1536
2025
Q4 		$288K Sell
25,704
-103
-0.4% -$1.18K ﹤0.01% 1594
2025
Q3 		$297K Sell
25,807
-1,697
-6% -$19.9K ﹤0.01% 1532
2025
Q2 		$336K Buy
27,504
+2,039
+8% +$25.6K ﹤0.01% 1487
2025
Q1 		$364K Sell
25,465
-601
-2% -$9.38K ﹤0.01% 1462
2024
Q4 		$414K Sell
26,066
-155
-0.6% -$3.07K ﹤0.01% 1452
2024
Q3 		$630K Sell
26,221
-731
-3% -$16.7K 0.01% 1308
2024
Q2 		$536K Sell
26,952
-1,345
-5% -$26.2K 0.01% 1340
2024
Q1 		$563K Sell
28,297
-495
-2% -$9.57K 0.01% 1319
2023
Q4 		$645K Sell
28,792
-392
-1% -$8.09K 0.01% 1230
2023
Q3 		$590K Sell
29,184
-1,522
-5% -$34.5K 0.01% 1243
2023
Q2 		$784K Sell
30,706
-1,135
-4% -$29.9K 0.01% 1114
2023
Q1 		$946K Sell
31,841
-537
-2% -$15.6K 0.01% 1010
2022
Q4 		$876K Buy
32,378
+194
+0.6% +$4.74K 0.01% 1046
2022
Q3 		$700K Sell
32,184
-3,611
-10% -$94.3K 0.01% 1116
2022
Q2 		$978K Buy
35,795
+2,275
+7% +$65.4K 0.01% 981
2022
Q1 		$1.12M Sell
33,520
-600
-2% -$19.3K 0.01% 947
2021
Q4 		$1.18M Sell
34,120
-985
-3% -$31.8K 0.01% 989
2021
Q3 		$1.09M Buy
35,105
+1,825
+5% +$61.9K 0.01% 1038
2021
Q2 		$1.21M Buy
33,280
+25,765
+343% +$1.07M 0.01% 973
2021
Q1 		$328K Sell
7,515
-257
-3% -$12.1K ﹤0.01% 1544
2020
Q4 		$356K Sell
7,772
-389
-5% -$16.2K ﹤0.01% 1480
2020
Q3 		$271K Sell
8,161
-333
-4% -$10.6K ﹤0.01% 1463
2020
Q2 		$249K Buy
8,494
+252
+3% +$7.29K ﹤0.01% 1489
2020
Q1 		$221K Buy
8,242
+363
+5% +$10.8K ﹤0.01% 1424
2019
Q4 		$265K Sell
7,879
-600
-7% -$21.7K ﹤0.01% 1511
2019
Q3 		$317K Buy
+8,479
New +$323K ﹤0.01% 1431

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

State of Alaska Department of Revenue's AVNS Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Avanos Medical (AVNS) stake by 30% in Q2 2026, selling an estimated $183K and leaving 17,879 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

State of Alaska Department of Revenue first reported a position in AVNS in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.21M in Q2 2021. 171 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • State of Alaska Department of Revenue held 17,879 shares of Avanos Medical worth $444K as of Q2 2026.
  • State of Alaska Department of Revenue sold 7,825 Avanos Medical shares in Q2 2026, an estimated $183K.
  • Avanos Medical made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1447 holding.
  • State of Alaska Department of Revenue first reported a position in Avanos Medical in Q3 2019 and has held it in 28 quarters since.
  • State of Alaska Department of Revenue's Avanos Medical position peaked at $1.21M in Q2 2021.
  • 171 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.